Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 597

1.

Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway.

Chen K, Zhang S, Ji Y, Li J, An P, Ren H, Liang R, Yang J, Li Z.

PLoS One. 2013 Sep 6;8(9):e72927. doi: 10.1371/journal.pone.0072927.

2.

Baicalein reduces the invasion of glioma cells via reducing the activity of p38 signaling pathway.

Zhang Z, Lv J, Lei X, Li S, Zhang Y, Meng L, Xue R, Li Z.

PLoS One. 2014 Feb 28;9(2):e90318. doi: 10.1371/journal.pone.0090318. Retraction in: PLoS One. 2016;11(7):e0160194.

3.

Baicalein inhibits the invasion of gastric cancer cells by suppressing the activity of the p38 signaling pathway.

Yan X, Rui X, Zhang K.

Oncol Rep. 2015 Feb;33(2):737-43. doi: 10.3892/or.2014.3669.

PMID:
25502212
5.
7.

Effects of laver extracts on adhesion, invasion, and migration in SK-Hep1 human hepatoma cancer cells.

Do Thi N, Hwang ES.

Biosci Biotechnol Biochem. 2014;78(6):1044-51. doi: 10.1080/09168451.2014.912116.

PMID:
25036133
8.

Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9.

Liu J, Wen X, Liu B, Zhang Q, Zhang J, Miao H, Zhu R.

Mol Med Rep. 2016 Mar;13(3):2401-8. doi: 10.3892/mmr.2016.4872.

9.

Knockdown of glucose-regulated protein 78 decreases the invasion, metalloproteinase expression and ECM degradation in hepatocellular carcinoma cells.

Li H, Song H, Luo J, Liang J, Zhao S, Su R.

J Exp Clin Cancer Res. 2012 Apr 30;31:39. doi: 10.1186/1756-9966-31-39.

11.

Up-regulation of TIMP-1 by genipin inhibits MMP-2 activities and suppresses the metastatic potential of human hepatocellular carcinoma.

Wang N, Zhu M, Tsao SW, Man K, Zhang Z, Feng Y.

PLoS One. 2012;7(9):e46318. doi: 10.1371/journal.pone.0046318.

12.

Antimetastatic effects of norcantharidin on hepatocellular carcinoma by transcriptional inhibition of MMP-9 through modulation of NF-kB activity.

Yeh CB, Hsieh MJ, Hsieh YH, Chien MH, Chiou HL, Yang SF.

PLoS One. 2012;7(2):e31055. doi: 10.1371/journal.pone.0031055.

13.
14.

GHGKHKNK octapeptide (P-5m) inhibits metastasis of HCCLM3 cell lines via regulation of MMP-2 expression in in vitro and in vivo studies.

Han X, Yan DM, Zhao XF, Matsuura H, Ding WG, Li P, Jiang S, Du BR, Du PG, Zhu X.

Molecules. 2012 Feb 2;17(2):1357-72. doi: 10.3390/molecules17021357. Erratum in: Molecules. 2012;17(6):6996. Hiroshi, Matsuura [corrected to Matsuura, Hiroshi].

15.
16.

Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.

Chen RX, Xia YH, Xue TC, Zhang H, Ye SL.

Oncol Rep. 2011 Mar;25(3):803-8. doi: 10.3892/or.2010.1116.

PMID:
21174062
17.

Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway.

Lu Z, Lu N, Li C, Li F, Zhao K, Lin B, Guo Q.

Toxicol Lett. 2012 Mar 25;209(3):211-20. doi: 10.1016/j.toxlet.2011.12.022.

PMID:
22245252
18.

Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice.

Xiao CL, Tao ZH, Guo L, Li WW, Wan JL, Sun HC, Wang L, Tang ZY, Fan J, Wu WZ.

BMC Cancer. 2011 Apr 22;11:150. doi: 10.1186/1471-2407-11-150.

19.
20.

Curcumin inhibits the proliferation and invasiveness of MHCC97-H cells via p38 signaling pathway.

Zhang K, Rui X, Yan X.

Drug Dev Res. 2014 Nov;75(7):463-8. doi: 10.1002/ddr.21210.

PMID:
25195681
Items per page

Supplemental Content

Support Center